CBPO [China Biologic Products] 6-K: (Original Filing)

[China Biologic Reports Financial Results for the Second Quarter of 2020 BEIJING, China – August 17, 2020 – Second Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable]

CBPO [China Biologic Products] 6-K: China Biologic Reports Financial Results for the Second

[China Biologic Reports Financial Results for the Second Quarter of 2020 BEIJING, China – August 17, 2020 – Second Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable]

CBPO [China Biologic Products] 6-K: (Original Filing)

[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]

CBPO [China Biologic Products] 6-K: FOR RELEASE June 29, 2020 China Biologic Provides

[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]

CBPO [China Biologic Products] 6-K: FOR RELEASE June 29, 2020 China Biologic Provides

[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]

CBPO [China Biologic Products] 6-K: (Original Filing)

[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]

CBPO [China Biologic Products] 6-K: (Original Filing)

[China Biologic Reports Financial Results for the First Quarter of 2020 BEIJING, China – May 20, 2020 – First Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable to t]

CBPO [China Biologic Products] 6-K: China Biologic Reports Financial Results for the First

[China Biologic Reports Financial Results for the First Quarter of 2020 BEIJING, China – May 20, 2020 – First Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable to t]

CBPO [China Biologic Products] 6-K: (Original Filing)

[China Biologic Reports Financial Results for the First Quarter of 2020 BEIJING, China – May 20, 2020 – First Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable to t]

CBPO [China Biologic Products] 6-K: China Biologic Reports Financial Results for the First

[China Biologic Reports Financial Results for the First Quarter of 2020 BEIJING, China – May 20, 2020 – First Quarter 2020 Financial Highlights · Total sales · Gross profit Gross margin · Income from operations Operating margin · Non-GAAP adjusted income from operations · Net income attributable to t]

Skip to toolbar